Alerts

Questions and answers about Dextropropoxyphene

Consumers and health professionals are advised that Smith & Nephew, in consultation with the TGA, has issued a hazard alert regarding the femoral implant component of the Journey Bi-Cruciate Stabilised (BCS) knee replacement system.

Phen Tabz tablets are banned in Australia because they contain a hidden, dangerous chemical (DMAA) that can seriously harm your health.

New conditions for Di-Gesic and Doloxene (dextropropoxyphene) took effect on 10 October 2013 to ensure safe use, changing how these pain-killers are prescribed and supplied.

The TGA has tested two samples of a product labelled Prosolution tablets and found that one counterfeit sample contained tadalafil and sildenafil.

New conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.

Owners and people responsible for HeartSine PAD 300/PAD 300P public access defibrillators are advised that Aero Healthcare, in consultation with the TGA, undertook a recall for product correction of some of these devices in November 2012 to correct certain battery and software problems that may affect the ability of the device to work in the event it is needed.

Ausmedic Australia is undertaking a recall for product correction for certain models of Viper and Viper Plus powered wheelchairs

Consumers and health professionals are advised that Hill-Rom, in consultation with the TGA, is undertaking a recall for product correction for the Liko Standard SlingBar 450.